文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

在血管加压素与感染性休克试验中采用联合纵向与时间-事件模型评估器官功能障碍的病程

Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial.
PubMed 文献 · Crit Care Explor · 2020-04-29
一句话结论在感染性休克患者中,去甲肾上腺素组前4天SOFA评分改善较血管加压素组更快,但第4天后两组SOFA评分趋同重叠。

该研究为血管加压素与感染性休克试验的二次分析,纳入加拿大、澳大利亚和美国27个ICU的763例感染性休克患者,随机接受盲法血管加压素(n=389)或去甲肾上腺素(n=374)输注。每日计算SOFA评分至出院、死亡或随机化后第28天,去甲肾上腺素组28天死亡率数值上更高(39% vs 35%,p=0.25),且SOFA评分越高与患者死亡率正相关,提示SOFA评分可能因死亡而受到信息性删失偏倚。最佳拟合的联合纵向(线性混合效应模型)与生存(Cox比例风险模型)模型显示,去甲肾上腺素与至第4天总SOFA评分更快速改善相关,之后每日SOFA评分趋同并在研究期剩余时间重叠。联合模型是一种可及的方法,可用于重症监护试验中评估干预对关键结局纵向进展的影响,这些结局可能被死亡或其他删失事件信息性截断。

要点

  • 去甲肾上腺素组至第4天总SOFA评分改善较血管加压素组更快,但第4天后两组每日SOFA评分趋同重叠。
  • 去甲肾上腺素组28天死亡率为39%,血管加压素组为35%,差异未达统计学显著(p=0.25)。
  • 较高的SOFA评分与患者死亡率呈正相关,提示SOFA评分可能因死亡而受到信息性删失。
  • 联合纵向与时间-事件模型可帮助减少信息性删失带来的潜在偏倚,适用于重症监护试验。

适用人群与场景

  • 感染性休克患者,来自加拿大、澳大利亚和美国27个ICU,共763例,随机接受盲法血管加压素(n=389)或去甲肾上腺素(n=374)输注。

处置流程与药物剂量

  • 血管加压素组接受盲法血管加压素输注,去甲肾上腺素组接受盲法去甲肾上腺素输注。

研究设计与关键结果

  • 研究类型为血管加压素与感染性休克试验数据的二次分析,纳入27个ICU的763例感染性休克患者,干预为盲法血管加压素输注(n=389)vs 去甲肾上腺素输注(n=374)。
  • 每日计算SOFA评分至出院、死亡或随机化后第28天。
  • 去甲肾上腺素组28天死亡率为39%,血管加压素组为35%(p=0.25),去甲肾上腺素组数值上更高。
  • 较高的SOFA评分与患者死亡率呈正相关。
  • 最佳拟合的联合纵向(线性混合效应模型)与生存(Cox比例风险模型)模型显示,去甲肾上腺素与至第4天总SOFA评分更快速改善相关,之后每日SOFA评分趋同并在研究期剩余时间重叠。

证据类型、等级与局限

  • 证据类型:血管加压素与感染性休克试验数据的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在感染性休克试验中,比较SOFA评分等非死亡结局时需考虑死亡导致的信息性删失偏倚,联合纵向与时间-事件模型可用于减少该偏倚。
  • 作者认为,联合模型是一种可及的方法,可用于重症监护试验中评估干预对关键结局(如器官功能障碍、生物标志物或生活质量)纵向进展的影响,这些结局可能被死亡或其他删失事件信息性截断。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Non-mortality septic shock outcomes (e.g., Sequential Organ Failure Assessment score) are important clinical endpoints in pivotal sepsis trials. However, comparisons of observed longitudinal non-mortality outcomes between study groups can be biased if death is unequal between study groups or is associated with an intervention (i.e., informative censoring). We compared the effects of vasopressin versus norepinephrine on the Sequential Organ Failure Assessment score in the Vasopressin and Septic Shock Trial to illustrate the use of joint modeling to help minimize potential bias from informative censoring.

DESIGN: Secondary analysis of the Vasopressin and Septic Shock Trial data.

SETTING: Twenty-seven ICUs in Canada, Australia, and United States.

SUBJECTS: Seven hundred sixty-three participants with septic shock who received blinded vasopressin (n = 389) or norepinephrine infusions (n = 374).

MEASUREMENTS AND MAIN RESULTS: Sequential Organ Failure Assessment scores were calculated daily until discharge, death, or day 28 after randomization. Mortality was numerically higher in the norepinephrine arm (28 d mortality of 39% vs 35%; p = 0.25), and there was a positive association between higher Sequential Organ Failure Assessment scores and patient mortality, characteristics that suggest a potential for bias from informative censoring of Sequential Organ Failure Assessment scores by death. The best-fitting joint longitudinal (i.e., linear mixed-effects model) and survival (i.e., Cox proportional hazards model for the time-to-death) model showed that norepinephrine was associated with a more rapid improvement in the total Sequential Organ Failure Assessment score through day 4, and then the daily Sequential Organ Failure Assessment scores converged and overlapped for the remainder of the study period.

CONCLUSIONS: Short-term reversal of organ dysfunction occurred more rapidly with norepinephrine compared with vasopressin, although differences between study arms did not persist after day 4. Joint models are an accessible methodology that could be used in critical care trials to assess the effects of interventions on the longitudinal progression of key outcomes (e.g., organ dysfunction, biomarkers, or quality of life) that may be informatively truncated by death or other censoring events.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Harhay MO, Gasparini A, Walkey AJ, et al. Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial. Crit Care Explor. 2020. PMID: 32426746. doi:10.1097/CCE.0000000000000104

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。